Cardioprotective Effects of Sodium-Glucose Cotransporter 2 Inhibitors and Their Possible Association With Normalization of the Circadian Index of Heart Rhythm
CONCLUSION: The use of SGLT2 inhibitors during early treatment can favorably affect both autonomic dysfunction and functional effort capacity of patients with type 2 diabetes with ischemic HFrEF.PMID:38083821 | DOI:10.14503/THIJ-23-8196
Source: Texas Heart Institute Journal - Category: Cardiology Authors: Nazile Bilgin Dogan Hamiyet Yilmaz Yasar Baris Kilicaslan Source Type: research
More News: Cardiology | Dapagliflozin | Diabetes | Diabetes Type 2 | Empagliflozin | Endocrinology | Forxiga | Heart | Heart Failure | Jardiance | Laboratory Medicine | SGLT2 Inhibitors | Sodium | Sports Medicine | Statistics | Study